Infinitopes Raises USD 35.1 Million to Advance Precision Cancer Vaccine into First-in-Human Trial
Infinitopes, a clinical-stage biotechnology company developing cancer vaccines, has completed the second close of its seed financing round, raising an additional USD 15.4 million and bringing total funds secured to USD 35.1 million.
Infinitopes | 21/01/2026 | By Darshana | 165
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy